Milpro 4 mg/10 mg Film-coated Tablets for Small Cats and Kittens

It is recommended to treat all the animals living in the same household
concomitantly.
In order to develop an effective worm control programme local epidemiological
information and the living conditions of the cat should be taken into account and
therefore it is recommended to seek professional advice.
Parasite resistance to any particular class of anthelmintic may develop following
frequent, repeated use of an anthelmintic of that class.
When Dipylidium caninum infection is present, concomitant treatment against
intermediate hosts, such as fleas and lice, should be considered to prevent re-
infection.

Special precautions for safe use in the target species:
No studies have been performed with severely debilitated cats or individuals with
seriously compromised kidney or liver function. The veterinary medicinal product is
not recommended for such animals or only according to the benefit-risk assessment
by the responsible veterinarian.
Studies have shown that treatment of dogs with a high number of circulating
microfilariae can sometimes lead to the appearance of hypersensitivity reactions,
such as pale mucous membranes, vomiting, trembling, laboured breathing or
excessive salivation. These reactions are associated with the release of proteins
from dead or dying microfilariae and are not a direct toxic effect of the veterinary
medicinal product. In the absence of data on cats with microfilaraemia, its use
should be according to a benefit risk assessment by the attending veterinarian.
The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out
of reach of the animals.
As per good veterinary practice, animals should be weighed to ensure accurate
dosing.
Ensure cats and kittens weighing between 0.5 kg and ≤2 kg receive the appropriate
tablet strength (4 mg MBO/10 mg praziquantel) and the appropriate dose (1/2 or 1
tablet) for the corresponding weight band (1/2 tablet for cats weighing 0.5 to 1 kg ; 1
tablet for cats weighing >1 to 2 kg – 1 tablet).
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Do not handle this veterinary medicinal product in case of hypersensitivity to the
active substances or to any of the excipients.
Wash hands after use.
Part tablets should be returned to the open blister pack and stored in the carton.
In case of accidental ingestion of the tablets, particularly by a child, seek medical
advice immediately and show the package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable
disease to the World Organisation for Animal Health (WOAH), specific guidelines on
the treatment and follow-up, and on the safeguard of persons, need to be obtained
from the relevant competent authority.